Humana Inc. (HUM) financials: revenue, earnings and cash flow
Fiscal 2016–2025 + TTM · from SEC filings · data as of November 13, 2026
Summary
Humana’s revenue went from $54.4B in fiscal 2016 to $129.7B in fiscal 2025, growth of about 10.1% a year.
Net income in fiscal 2025 was $1.2B, a net margin of 0.9%; the best year in this period was 2020 with $3.4B.
Over the twelve months to September 30, 2026, revenue was $154.2B and net income $1.2B.
Free cash flow was $375M in fiscal 2025 and positive in 10 of the 10 years shown.
The diluted share count fell 20% over the period (buybacks).
Revenue, profit and cash flow by year
Income statement
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $154.2B | $129.7B | $117.8B | $106.4B | $92.9B | $83.1B | $77.2B | $64.9B | $56.9B | $53.8B | $54.4B |
| Gross profit | — | — | — | — | — | — | — | — | — | — | — |
| Operating income | $2.4B | $2.7B | $2.6B | $4.0B | $3.8B | $3.1B | $5.0B | $3.2B | $3.1B | $4.3B | $1.7B |
| Net income | $1.2B | $1.2B | $1.2B | $2.5B | $2.8B | $2.9B | $3.4B | $2.7B | $1.7B | $2.4B | $614M |
| EPS (diluted) | $10.30 | $9.84 | $9.98 | $20.00 | $22.08 | $22.67 | $25.31 | $20.10 | $12.16 | $16.81 | $4.07 |
| R&D | — | — | — | — | — | — | — | — | — | — | — |
| Revenue growth | — | +10.1% | +10.7% | +14.5% | +11.8% | +7.7% | +18.9% | +14.0% | +5.9% | −1.1% | +0.2% |
Cash flow
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $3.7B | $921M | $3.0B | $4.0B | $4.6B | $2.3B | $5.6B | $5.3B | $2.2B | $4.1B | $1.9B |
| Capital spending | -$592M | -$546M | -$575M | -$1.0B | -$1.1B | -$1.3B | -$964M | -$736M | -$612M | -$524M | -$527M |
| Free cash flow | $3.1B | $375M | $2.4B | $3.0B | $3.5B | $920M | $4.7B | $4.5B | $1.6B | $3.5B | $1.4B |
| Dividends paid | $429M | $430M | $431M | $431M | $98M | $90M | $323M | $291M | $265M | $220M | $177M |
| Buybacks | $152M | $151M | $817M | $1.6B | $2.1B | $79M | $1.8B | $1.1B | $1.1B | $3.4B | $104M |
| Stock-based pay | $231M | $241M | $207M | $175M | $216M | $180M | $181M | $163M | $137M | $157M | $115M |
Balance sheet
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash | — | $19.9B | $20.4B | $21.3B | $18.9B | $16.6B | $17.2B | $15.0B | $12.4B | $13.6B | $11.5B |
| Debt | — | $12.9B | $12.2B | $12.2B | $11.7B | $13.2B | $7.1B | $6.1B | $6.1B | $4.9B | $4.1B |
| Equity | — | $17.7B | $16.4B | $16.3B | $15.3B | $16.1B | $13.7B | $12.0B | $10.2B | $9.8B | $10.7B |
| Total assets | — | $48.9B | $46.5B | $47.1B | $43.1B | $44.4B | $35.0B | $29.1B | $25.4B | $27.2B | $25.4B |
| Shares (diluted) | 122M | 121M | 121M | 124M | 127M | 129M | 133M | 135M | 138M | 146M | 151M |
Margins and returns
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | — | — | — | — | — | — | — | — | — | — | — |
| Operating margin | 1.5% | 2.1% | 2.2% | 3.8% | 4.1% | 3.8% | 6.5% | 4.9% | 5.5% | 7.9% | 3.2% |
| Net margin | 0.8% | 0.9% | 1.0% | 2.3% | 3.0% | 3.5% | 4.4% | 4.2% | 3.0% | 4.5% | 1.1% |
| FCF margin | 2.0% | 0.3% | 2.0% | 2.8% | 3.7% | 1.1% | 6.1% | 7.0% | 2.7% | 6.6% | 2.6% |
| ROIC | — | 7.3% | 6.7% | 10.5% | 11.1% | 9.2% | 17.2% | 13.7% | 15.5% | 17.6% | 9.3% |
| ROE | — | 6.7% | 7.4% | 15.3% | 18.3% | 18.2% | 24.5% | 22.5% | 16.6% | 24.9% | 5.8% |
Frequently asked questions
What is Humana’s annual revenue?
$129.7B in fiscal 2025 and $154.2B over the twelve months to September 30, 2026.
How much profit does Humana make?
Net income was $1.2B in fiscal 2025 (net margin 0.9%).
Is Humana’s revenue growing?
Yes: revenue rose 10.1% in fiscal 2025 compared with the year before.
From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.